688016.SS SHH
Shanghai MicroPort Endovascular MedTech Co., Ltd.
1W: -0.1%
1M: -3.9%
3M: -5.5%
YTD: -13.7%
1Y: -22.0%
3Y: -23.6%
5Y: -61.2%
¥85.48 ($12.75)
+1.64 (+1.96%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.4B
+12.0% ▲
5Y CAGR: +23.5%
Gross Profit
$1.4B
+54.2% ▲
5Y CAGR: +29.7%
Operating Income
$654M
-1.1% ▼
5Y CAGR: +21.2%
Net Income
$563M
+12.2% ▲
5Y CAGR: +21.3%
EPS (Diluted)
$4.65
+14.3% ▲
5Y CAGR: +18.4%
EBITDA
$688M
-0.1% ▼
5Y CAGR: +24.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $685M | $897M | $1.2B | $1.2B | $1.4B |
| YoY Growth | +45.6% | +30.9% | +32.4% | +1.6% | +12.0% |
| Cost of Revenue | $154M | $225M | $286M | $330M | $0 |
| Gross Profit | $531M | $672M | $901M | $876M | $1.4B |
| Gross Margin | 77.5% | 74.9% | 75.9% | 72.6% | 100.0% |
| R&D Expenses | $102M | $138M | $173M | $94M | $0 |
| SG&A Expenses | $104M | $150M | $185M | $250M | $0 |
| Operating Expenses | $168M | $257M | $327M | $215M | $697M |
| Operating Income | $363M | $415M | $574M | $661M | $654M |
| Operating Margin | 53.0% | 46.3% | 48.3% | 54.8% | 48.4% |
| Interest Expense | $2M | $2M | $2M | $2M | $0 |
| Income Before Tax | $362M | $414M | $572M | $652M | $653M |
| Tax Expense | $48M | $62M | $85M | $159M | $90M |
| Net Income | $316M | $357M | $492M | $502M | $563M |
| Net Margin | 46.1% | 39.8% | 41.5% | 41.6% | 41.7% |
| EPS (Diluted) | $2.95 | $3.33 | $6.37 | $4.07 | $4.65 |
| EBITDA | $333M | $396M | $556M | $554M | $688M |
| Shares Outstanding | 72M | 72M | 77M | 123M | 121M |